Study of WVE-007 for overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests an experimental drug called WVE-007 for people who are overweight or have obesity. It aims to help with weight loss and is looking at both a group without diabetes and a group with prediabetes or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your weight is stable — you haven't gained or lost more than 5% in the last 3–6 months.
- You are generally healthy, with no major heart, thyroid, or liver issues.
- You are not currently taking prescription weight-loss meds, certain psychiatric meds, or more than 2 blood pressure or cholesterol medications.
- You have not received an experimental drug or an siRNA agent in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Hear when a new Overweight and Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.